• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

The prevalence of obesity has reached pandemic proportions worldwide and certainly in the
United States. Obesity is a well-established independent risk factor for development of many …

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is associated with
substantial morbidity, mortality, and healthcare use. Great strides have been made in stroke …

The past 3 decades have been characterized by an exponential growth in knowledge and
advances in the clinical treatment of atrial fibrillation (AF). It is now known that AF genesis …

Both obesity and atrial fibrillation (AF) are increasing in epidemic proportions, and both
increase the prevalence of cardiovascular disease events. Obesity has adverse effects on …

Background An integrated care approach might be of benefit for clinical outcomes of patients
with atrial fibrillation (AF). This study evaluated whether compliance with the Atrial fibrillation …

Background: Oral anticoagulation reduces the risk of mortality in atrial fibrillation (AF), but
examination of the causes of death is essential to design new strategies to further reduce the …

Background Patients with atrial fibrillation are known to have a high risk of mortality. There is
a paucity of population-based studies about the impact of atrial fibrillation on the mortality …